Versant Venture Management as of June 30, 2022
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 8 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CRISPR Therapeutics Common Shares (CRSP) | 46.4 | $30M | 499k | 60.77 | |
| Passage Bio Common Stock | 17.9 | $12M | 5.0M | 2.36 | |
| Gritstone Oncology Common Stock (GRTSQ) | 13.2 | $8.6M | 3.6M | 2.42 | |
| Adverum Biotechnologies Common Stock | 9.3 | $6.1M | 5.1M | 1.20 | |
| Minerva Surgical Common Stock | 6.0 | $3.9M | 1.7M | 2.35 | |
| Aligos Therapeutics Common Stock | 4.3 | $2.8M | 2.3M | 1.21 | |
| CymaBay Therapeutics Common Stock | 2.5 | $1.6M | 544k | 2.95 | |
| Clovis Oncology Common Stock | 0.3 | $183k | 102k | 1.80 |
